NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHLBI E-284-2015-0-PCT-02 SEGMENTED MRI CATHETERS AND OTHER INTERVENTIONAL DEVICES PCT PCT PCT/US2016/051600 Expired
NHLBI E-284-2015-0-EP-03 SEGMENTED MRI CATHETERS AND OTHER INTERVENTIONAL DEVICES EP National Stage 16847168.8 Pending
NIAID E-251-2016-0-US-01 METHODS OF DIAGNOSING AND TREATING CD55 DEFICIENCY HYPERACTIVATION OF COMPLEMENT, ANGIOPATHIC THROMBOSIS AND PROTEIN LOSING ENTEROPATHY (CHAPLE), A NEWLY IDENTIFIED ORPHAN DISEASE US 62/394,630 Abandoned
NCI E-269-2015-0-PCT-02 METHODS OF ISOLATING TUMOR-REACTIVE T CELL RECEPTORS FROM TUMOR OR PERIPHERAL BLOOD PCT PCT PCT/US2016/051227 Expired
NCI E-265-2015-0-CA-04 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS CA National Stage 2998869 Issued
NCI E-265-2015-0-SG-13 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` SG National Stage 11201802069U Issued
NCI E-265-2015-0-SA-12 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` SA National Stage 518391109 Issued
NCI E-265-2015-0-CN-05 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` CN National Stage 201680058891.3 Issued
NCI E-265-2015-0-IE-28 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS IE EP 16770408.9 Issued
NCI E-265-2015-0-DE-23 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS DE EP 16770408.9 Issued
NCI E-265-2015-0-BE-21 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS BE EP 16770408.9 Issued
NCI E-265-2015-0-CH-22 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS CH EP 16770408.9 Issued
NCI E-265-2015-0-SE-32 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS SE EP 16770408.9 Issued
NCI E-265-2015-0-ES-25 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS ES EP 16770408.9 Issued
NCI E-265-2015-0-NO-31 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS NO EP 16770408.9 Issued
NCI E-265-2015-0-NL-30 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS NL EP 16770408.9 Issued
NCI E-265-2015-0-FR-26 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS FR EP 16770408.9 Issued
NCI E-265-2015-0-DK-24 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS DK EP 16770408.9 Issued
NCI E-265-2015-0-IT-29 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS IT EP 16770408.9 Issued
NCI E-265-2015-0-EP-06 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS EP National Stage 16770408.9 Issued
NCI E-265-2015-0-GB-27 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS GB EP 16770408.9 Issued
NCI E-265-2015-0-AU-03 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` AU National Stage 2016323017 Issued
NCI E-269-2010-0-CA-04 ANTI-SSX-2 T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE CA National Stage 2811788 Issued
NCI E-265-2015-0-PCT-02 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` PCT PCT PCT/US2016/050875 Expired
NIAID E-185-2015-0-PCT-02 Expression Vector Delivery System and Use Thereof for Inducing an Immune Response PCT PCT PCT/US2016/051037 Expired
NCI E-243-2015-0-PCT-02 Anti-CD276 Chimeric Antigen Receptors PCT PCT PCT/US2016/050887 Expired
NICHD E-187-2012-0-US-04 SYSTEM WITH AN ELECTROMAGENTIC FIELD GENERATOR WITH COILS FOR TREATING TUMORS AND A METHOD FOR TREATING TISSUE US National Stage 15/125,079 Abandoned
NIAID E-185-2015-0-EP-03 Expression Vector Delivery System and Use Thereof for Inducing an Immune Response EP National Stage 16775023.1 Pending
NCI E-016-2016-0-US-01 Synergistic Anti-Tumor Effect of HMG Protein in Combination with Anti-CD4 Antibody or Immune Checkpoint Regulator US 62/385,588 Abandoned
NCI E-262-2005-0-CA-32 Mutated Pseudomonas Exotoxins with Reduced Antigenicity CA DIV 2941466 Issued
NEI E-212-2015-0-EP-05 METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS EP National Stage 16766444.0 Issued
NEI E-212-2015-0-PCT-02 METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS PCT PCT PCT/US2016/050543 Expired
NEI E-212-2015-0-CA-04 METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS CA National Stage 2997952 Pending
NCI E-171-2018-9-US-03 MODIFIED CELLS AND METHODS OF THERAPY US CON 15/256,086 11147837 Issued PDF
NCI E-170-2010-0-US-07 LINKED PURINE PTERIN HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS US CON 15/255,466 Abandoned
NIAID E-228-2016-0-US-01 STABILIZED GROUP 2 INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF US 62/383,267 Abandoned
NCI E-234-2014-1-KR-09 METHODS FOR PRODUCING AUTOLOGOUS T CELLS USEFUL TO TREAT B CELL MALIGNANCIES AND OTHER CANCERS AND COMPOSITIONS THEREOF KR National Stage 10-2016-7024014 Abandoned
NCI E-171-2018-9-US-02 MODIFIED CELLS AND METHODS OF THERAPY US CON 15/250,514 10406177 Issued PDF
NHGRI E-161-2015-0-PCT-02 A METHOD OF DETECTING MOLECULES IN PROXIMITY TO A TARGET MOLECULE IN A SAMPLE PCT PCT PCT/US2016/492630 Expired
NHGRI E-161-2015-0-EP-03 A METHOD OF DETECTING MOLECULES IN PROXIMITY TO A TARGET MOLECULE IN A SAMPLE EP National Stage 16762944.3 Abandoned
NICHD E-302-2011-0-US-07 Identification Of Two Novel Biomarkers For Niemann-Pick Disease Type C US DIV 15/250,449 Abandoned
NIAID E-168-2016-0-US-01 TISSUE CLEARING METHOD US 62/380,593 Abandoned
NCATS E-202-2016-3-US-01 Repurposing CDK Inhibitors For Treatment Of Zika Virus Infection US 62/380,778 Abandoned
NIAID E-139-2006-0-AU-63 Development Of Dengue Virus Vaccine Components AU DIV 2016219680 Issued
NCI E-254-2016-0-US-01 Fragment-based Binding Pocket Optimization Of Ligand Of The Pol-o-like Kinase 1 Interactions Within 1 (P1k1) Pol-o-box A Key Cryptic Domain (PBD) US 62/380,002 Abandoned
NIAID E-256-2015-2-CA-03 Modified Anthrax Toxin Protective Antigen CA National Stage 2996767 Issued
NCATS E-072-2012-0-US-05 Modulators of the Relaxin Receptor 1 US CON 15/247,438 10125112 Issued PDF
NIAID E-256-2015-2-PCT-01 Modified Anthrax Toxin Protective Antigen PCT PCT COMB PCT/US2016/048706 Expired
NIAID E-256-2015-2-CN-04 Modified Anthrax Toxin Protective Antigen CN National Stage 201680062198.3 Abandoned
NIAID E-256-2015-2-IN-06 Modified Anthrax Toxin Protective Antigen IN National Stage 201817007478 Abandoned